Russo A, Calo V, Bruno L, Rizzo S, Bazan V, Di Fede G: Hereditary ovarian cancer. Crit Rev Oncol Hematol. 2009, 69: 28-44. 10.1016/j.critrevonc.2008.06.003.
Article
PubMed
Google Scholar
Balch C, Fang F, Matei DE, Huang TH, Nephew KP: Minireview: epigenetic changes in ovarian cancer. Endocrinology. 2009, 150: 4003-4011. 10.1210/en.2009-0404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Knudson AG: Genetics of human cancer. Annu Rev Genet. 1986, 20: 231-251. 10.1146/annurev.ge.20.120186.001311.
Article
PubMed
Google Scholar
Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet. 1999, 21: 163-167. 10.1038/5947.
Article
CAS
PubMed
Google Scholar
Dryja TP, Mukai S, Petersen R, Rapaport JM, Walton D, Yandell DW: Parental origin of mutations of the retinoblastoma gene. Nature. 1989, 339: 556-558. 10.1038/339556a0.
Article
CAS
PubMed
Google Scholar
Huff V, Meadows A, Riccardi VM, Strong LC, Saunders GF: Parental origin of de novo constitutional deletions of chromosomal band 11p13. Am J Hum Genet. 1990, 47: 155-160.
CAS
PubMed
PubMed Central
Google Scholar
Kajii T, Ohama K: Androgenetic origin of hydatidiform mole. Nature. 1977, 268: 633-634. 10.1038/268633a0.
Article
CAS
PubMed
Google Scholar
Mutter GL: Teratoma genetics and stem cells: a review. Obstet Gynecol Surv. 1987, 42: 661-670.
Article
CAS
PubMed
Google Scholar
Feinberg AP: DNA methylation, genomic imprinting and cancer. Curr Top Microbiol Immunol. 2000, 249: 87-99. 10.1007/978-3-642-59696-4_6.
CAS
PubMed
Google Scholar
Joyce JA, Schofield PN: Genomic imprinting and cancer. Mol Pathol. 1998, 51: 185-190. 10.1136/mp.51.4.185.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feinberg AP: Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res. 1999, 59: 1743-1746.
Google Scholar
Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al: Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA. 2008, 105: 7004-7009. 10.1073/pnas.0801615105.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kohda T, Asai A, Kuroiwa Y, Kobayashi S, Aisaka K, Nagashima G, et al: Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells. 2001, 6: 237-247. 10.1046/j.1365-2443.2001.00412.x.
Article
CAS
PubMed
Google Scholar
Nakano S, Murakami K, Meguro M, Soejima H, Higashimoto K, Urano T, et al: Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci. 2006, 97: 1147-1154. 10.1111/j.1349-7006.2006.00305.x.
Article
CAS
PubMed
Google Scholar
Kamikihara T, Arima T, Kato K, Matsuda T, Kato H, Douchi T, et al: Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer. Int J Cancer. 2005, 115: 690-700. 10.1002/ijc.20971.
Article
CAS
PubMed
Google Scholar
Surani MA: Imprinting and the initiation of gene silencing in the germ line. Cell. 1998, 93: 309-312. 10.1016/S0092-8674(00)81156-3.
Article
CAS
PubMed
Google Scholar
Koerner MV, Barlow DP: Genomic imprinting-an epigenetic gene-regulatory model. Curr Opin Genet Dev. 2010, 20: 164-170. 10.1016/j.gde.2010.01.009.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sato A, Hiura H, Okae H, Miyauchi N, Abe Y, Utsunomiya T, et al: Assessing loss of imprint methylation in sperm from subfertile men using novel methylation polymerase chain reaction Luminex analysis. Fertil Steril. 2011, 95: 129-134. 10.1016/j.fertnstert.2010.06.076.
Article
CAS
PubMed
Google Scholar
Reik W, Walter J: Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2001, 2: 21-32.
Article
CAS
PubMed
Google Scholar
Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, et al: Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Molecular cancer research: MCR. 2006, 4: 283-292. 10.1158/1541-7786.MCR-05-0138.
Article
CAS
PubMed
Google Scholar
Kobayashi H, Sato A, Otsu E, Hiura H, Tomatsu C, Utsunomiya T, et al: Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients. Hum Mol Genet. 2007, 16: 2542-2551. 10.1093/hmg/ddm187.
Article
CAS
PubMed
Google Scholar
Toguchida J, Ishizaki K, Sasaki MS, Nakamura Y, Ikenaga M, Kato M, et al: Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature. 1989, 338: 156-158. 10.1038/338156a0.
Article
CAS
PubMed
Google Scholar
Sato A, Otsu E, Negishi H, Utsunomiya T, Arima T: Aberrant DNA methylation of imprinted loci in superovulated oocytes. Hum Reprod. 2007, 22: 26-35.
Article
CAS
PubMed
Google Scholar
Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P: The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002, 19: 607-614. 10.1002/humu.10081.
Article
CAS
PubMed
Google Scholar
Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, et al: Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 1998, 58: 2095-2097.
CAS
PubMed
Google Scholar
Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, et al: High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin Cancer Res. 2007, 13: 4731-4739. 10.1158/1078-0432.CCR-07-0502.
Article
CAS
PubMed
Google Scholar
Milde-Langosch K, Ocon E, Becker G, Loning T: p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer. 1998, 79: 61-65. 10.1002/(SICI)1097-0215(19980220)79:1<61::AID-IJC12>3.0.CO;2-K.
Article
CAS
PubMed
Google Scholar
Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005, 5: 845-856. 10.1038/nrc1739.
Article
CAS
PubMed
Google Scholar
Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005, 5: 223-231. 10.1038/nrc1571.
Article
CAS
PubMed
Google Scholar
Cottrell SE, Laird PW: Sensitive detection of DNA methylation. Ann N Y Acad Sci. 2003, 983: 120-130. 10.1111/j.1749-6632.2003.tb05967.x.
Article
CAS
PubMed
Google Scholar
Li LC, Carroll PR, Dahiya R: Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst. 2005, 97: 103-115. 10.1093/jnci/dji010.
Article
CAS
PubMed
Google Scholar
Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, et al: Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res. 2004, 10: 5998-6005. 10.1158/1078-0432.CCR-04-0667.
Article
CAS
PubMed
Google Scholar
Zochbauer-Muller S, Minna JD, Gazdar AF: Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist. 2002, 7: 451-457. 10.1634/theoncologist.7-5-451.
Article
CAS
PubMed
Google Scholar
Henrique R, Jeronimo C: Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol. 2004, 46: 660-669. 10.1016/j.eururo.2004.06.014.
Article
CAS
PubMed
Google Scholar
Yang Q, Zage P, Kagan D, Tian Y, Seshadri R, Salwen HR, et al: Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res. 2004, 10: 8493-8500. 10.1158/1078-0432.CCR-04-1331.
Article
CAS
PubMed
Google Scholar
Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res. 2001, 61: 3225-3229.
CAS
PubMed
Google Scholar
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 2000, 24: 132-138. 10.1038/72785.
Article
CAS
PubMed
Google Scholar
Suzuki F, Akahira J, Miura I, Suzuki T, Ito K, Hayashi S, et al: Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 2008, 99: 2365-2372. 10.1111/j.1349-7006.2008.00988.x.
Article
CAS
PubMed
Google Scholar
Ueoka Y, Kato K, Kuriaki Y, Horiuchi S, Terao Y, Nishida J, et al: Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br J Cancer. 2000, 82: 891-899. 10.1054/bjoc.1999.1016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, et al: Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 2007, 67: 7095-7105. 10.1158/0008-5472.CAN-06-4567.
Article
CAS
PubMed
Google Scholar
Vambergue A, Fajardy I, Dufour P, Valat AS, Vandersippe M, Fontaine P, et al: No loss of genomic imprinting of IGF-II and H19 in placentas of diabetic pregnancies with fetal macrosomia. Growth Horm IGF Res. 2007, 17: 130-136. 10.1016/j.ghir.2007.01.001.
Article
CAS
PubMed
Google Scholar
Wylie AA, Murphy SK, Orton TC, Jirtle RL: Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res. 2000, 10: 1711-1718. 10.1101/gr.161600.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, et al: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 1993, 362: 749-751. 10.1038/362749a0.
Article
CAS
PubMed
Google Scholar
Maegawa S, Yoshioka H, Itaba N, Kubota N, Nishihara S, Shirayoshi Y, et al: Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol Carcinog. 2001, 31: 1-9. 10.1002/mc.1034.
Article
CAS
PubMed
Google Scholar
Pedersen IS, Dervan PA, Broderick D, Harrison M, Miller N, Delany E, et al: Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res. 1999, 59: 5449-5451.
CAS
PubMed
Google Scholar
Higashimoto K, Soejima H, Yatsuki H, Katsuki T, Mukai T: An NsiI RFLP in the human long QT intronic transcript 1 (LIT1). J Hum Genet. 2000, 45: 96-97. 10.1007/s100380050020.
Article
CAS
PubMed
Google Scholar
Mitsuya K, Meguro M, Lee MP, Katoh M, Schulz TC, Kugoh H, et al: An imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet. 1999, 8: 1209-1217. 10.1093/hmg/8.7.1209.
Article
CAS
PubMed
Google Scholar
MacDonald HR, Wevrick R: The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum Mol Genet. 1997, 6: 1873-1878. 10.1093/hmg/6.11.1873.
Article
CAS
PubMed
Google Scholar